Copyright Reports & Markets. All rights reserved.

Global Intravitreal Injectable Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Intravitreal Injectable
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Drug
    • 1.3.1 Overview: Global Intravitreal Injectable Consumption Value by Drug: 2018 Versus 2022 Versus 2029
    • 1.3.2 Anti-VEGF
    • 1.3.3 Steroids
    • 1.3.4 Others
  • 1.4 Market Analysis by Disease
    • 1.4.1 Overview: Global Intravitreal Injectable Consumption Value by Disease: 2018 Versus 2022 Versus 2029
    • 1.4.2 Macular Degeneration
    • 1.4.3 Macular Edema
    • 1.4.4 Uveitis
    • 1.4.5 Retinal Vein Occlusion
    • 1.4.6 Others
  • 1.5 Global Intravitreal Injectable Market Size & Forecast
    • 1.5.1 Global Intravitreal Injectable Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Intravitreal Injectable Sales Quantity (2018-2029)
    • 1.5.3 Global Intravitreal Injectable Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Regeneron Pharmaceuticals (Eylea)
    • 2.1.1 Regeneron Pharmaceuticals (Eylea) Details
    • 2.1.2 Regeneron Pharmaceuticals (Eylea) Major Business
    • 2.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product and Services
    • 2.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
  • 2.2 Allergan
    • 2.2.1 Allergan Details
    • 2.2.2 Allergan Major Business
    • 2.2.3 Allergan Intravitreal Injectable Product and Services
    • 2.2.4 Allergan Intravitreal Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Allergan Recent Developments/Updates
  • 2.3 EyePoint Pharmaceuticals
    • 2.3.1 EyePoint Pharmaceuticals Details
    • 2.3.2 EyePoint Pharmaceuticals Major Business
    • 2.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Product and Services
    • 2.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 EyePoint Pharmaceuticals Recent Developments/Updates
  • 2.4 Genentech
    • 2.4.1 Genentech Details
    • 2.4.2 Genentech Major Business
    • 2.4.3 Genentech Intravitreal Injectable Product and Services
    • 2.4.4 Genentech Intravitreal Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Genentech Recent Developments/Updates
  • 2.5 Kanghong Pharmaceutical
    • 2.5.1 Kanghong Pharmaceutical Details
    • 2.5.2 Kanghong Pharmaceutical Major Business
    • 2.5.3 Kanghong Pharmaceutical Intravitreal Injectable Product and Services
    • 2.5.4 Kanghong Pharmaceutical Intravitreal Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Kanghong Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Intravitreal Injectable by Manufacturer

  • 3.1 Global Intravitreal Injectable Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Intravitreal Injectable Revenue by Manufacturer (2018-2023)
  • 3.3 Global Intravitreal Injectable Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Intravitreal Injectable by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Intravitreal Injectable Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Intravitreal Injectable Manufacturer Market Share in 2022
  • 3.5 Intravitreal Injectable Market: Overall Company Footprint Analysis
    • 3.5.1 Intravitreal Injectable Market: Region Footprint
    • 3.5.2 Intravitreal Injectable Market: Company Product Type Footprint
    • 3.5.3 Intravitreal Injectable Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Intravitreal Injectable Market Size by Region
    • 4.1.1 Global Intravitreal Injectable Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Intravitreal Injectable Consumption Value by Region (2018-2029)
    • 4.1.3 Global Intravitreal Injectable Average Price by Region (2018-2029)
  • 4.2 North America Intravitreal Injectable Consumption Value (2018-2029)
  • 4.3 Europe Intravitreal Injectable Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Intravitreal Injectable Consumption Value (2018-2029)
  • 4.5 South America Intravitreal Injectable Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Intravitreal Injectable Consumption Value (2018-2029)

5 Market Segment by Drug

  • 5.1 Global Intravitreal Injectable Sales Quantity by Drug (2018-2029)
  • 5.2 Global Intravitreal Injectable Consumption Value by Drug (2018-2029)
  • 5.3 Global Intravitreal Injectable Average Price by Drug (2018-2029)

6 Market Segment by Disease

  • 6.1 Global Intravitreal Injectable Sales Quantity by Disease (2018-2029)
  • 6.2 Global Intravitreal Injectable Consumption Value by Disease (2018-2029)
  • 6.3 Global Intravitreal Injectable Average Price by Disease (2018-2029)

7 North America

  • 7.1 North America Intravitreal Injectable Sales Quantity by Drug (2018-2029)
  • 7.2 North America Intravitreal Injectable Sales Quantity by Disease (2018-2029)
  • 7.3 North America Intravitreal Injectable Market Size by Country
    • 7.3.1 North America Intravitreal Injectable Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Intravitreal Injectable Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Intravitreal Injectable Sales Quantity by Drug (2018-2029)
  • 8.2 Europe Intravitreal Injectable Sales Quantity by Disease (2018-2029)
  • 8.3 Europe Intravitreal Injectable Market Size by Country
    • 8.3.1 Europe Intravitreal Injectable Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Intravitreal Injectable Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Intravitreal Injectable Sales Quantity by Drug (2018-2029)
  • 9.2 Asia-Pacific Intravitreal Injectable Sales Quantity by Disease (2018-2029)
  • 9.3 Asia-Pacific Intravitreal Injectable Market Size by Region
    • 9.3.1 Asia-Pacific Intravitreal Injectable Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Intravitreal Injectable Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Intravitreal Injectable Sales Quantity by Drug (2018-2029)
  • 10.2 South America Intravitreal Injectable Sales Quantity by Disease (2018-2029)
  • 10.3 South America Intravitreal Injectable Market Size by Country
    • 10.3.1 South America Intravitreal Injectable Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Intravitreal Injectable Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Intravitreal Injectable Sales Quantity by Drug (2018-2029)
  • 11.2 Middle East & Africa Intravitreal Injectable Sales Quantity by Disease (2018-2029)
  • 11.3 Middle East & Africa Intravitreal Injectable Market Size by Country
    • 11.3.1 Middle East & Africa Intravitreal Injectable Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Intravitreal Injectable Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Intravitreal Injectable Market Drivers
  • 12.2 Intravitreal Injectable Market Restraints
  • 12.3 Intravitreal Injectable Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Intravitreal Injectable and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Intravitreal Injectable
  • 13.3 Intravitreal Injectable Production Process
  • 13.4 Intravitreal Injectable Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Intravitreal Injectable Typical Distributors
  • 14.3 Intravitreal Injectable Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
    According to our (Global Info Research) latest study, the global Intravitreal Injectable market size was valued at USD 14950 million in 2022 and is forecast to a readjusted size of USD 23690 million by 2029 with a CAGR of 6.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
    North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
    This report is a detailed and comprehensive analysis for global Intravitreal Injectable market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Drug and by Disease. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Intravitreal Injectable market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Intravitreal Injectable market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Intravitreal Injectable market size and forecasts, by Drug and by Disease, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Intravitreal Injectable market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Intravitreal Injectable
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Intravitreal Injectable market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech and Kanghong Pharmaceutical. etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Intravitreal Injectable market is split by Drug and by Disease. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Drug, and by Disease in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Drug
    Anti-VEGF
    Steroids
    Others
    Market segment by Disease
    Macular Degeneration
    Macular Edema
    Uveitis
    Retinal Vein Occlusion
    Others
    Major players covered
    Regeneron Pharmaceuticals (Eylea)
    Allergan
    EyePoint Pharmaceuticals
    Genentech
    Kanghong Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Intravitreal Injectable product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Intravitreal Injectable, with price, sales, revenue and global market share of Intravitreal Injectable from 2018 to 2023.
    Chapter 3, the Intravitreal Injectable competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Intravitreal Injectable breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Drug and disease, with sales market share and growth rate by drug, disease, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intravitreal Injectable market forecast, by regions, drug and disease, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Intravitreal Injectable.
    Chapter 14 and 15, to describe Intravitreal Injectable sales channel, distributors, customers, research findings and conclusion.

    Buy now